Publications by authors named "Peter A C Maple"

Claim this Profile
H
Human Alpha Herpesviruses Infections (HSV1, HSV2, and VZV), Alzheimer's Disease, and the Potential Benefits of Targeted Treatment or Vaccination-A Virological Perspective.
Peter A C Maple, Akram A Hosseini

Vaccines (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19, SARS-CoV-2 Vaccination, and Human Herpesviruses Infections.
Peter A C Maple

Vaccines (Basel)· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Sclerosis, Viruses, and New Vaccines.
Peter A C Maple

Neurol Int· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population (Antibody) Testing for COVID-19-Technical Challenges, Application and Relevance, an English Perspective.
Peter A C Maple

Vaccines (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Absence of Epstein-Barr Virus Reactivation and Associations with Disease Activity in People with Multiple Sclerosis Undergoing Therapeutic Hookworm Vaccination.
Peter A C Maple, Bruno Gran, Radu Tanasescu, David I Pritchard, Cris S Constantinescu

Vaccines (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A different response to cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infection in UK people with multiple sclerosis (PwMS) compared to controls.
Peter A C Maple, Radu Tanasescu, Bruno Gran, Cris S Constantinescu

J Infect· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development.
Peter A C Maple

Vaccines (Basel)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.
Peter A C Maple

Vaccines (Basel)· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Varicella zoster immune status in children treated for acute leukemia.
Soonie R Patel, Jessica Bate, Peter A C Maple, Kevin Brown, Judith Breuer

Pediatr Blood Cancer· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of past and recent parvovirus B19 infection in immunocompetent individuals by quantitative PCR and enzyme immunoassays: a dual-laboratory study.
Peter A C Maple, Lea Hedman, Pravesh Dhanilall, Kalle Kantola, Visa Nurmi

J Clin Microbiol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.
Nigel Field, Gayatri Amirthalingam, Pauline Waight, Nick Andrews, Shamez N Ladhani, Peter A C Maple

Vaccine· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Peter A C Maple, Stuart Beard, Ruth P Parry, Kevin E Brown

Transfusion· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis